» Articles » PMID: 29793508

GSK-3β Inhibits Autophagy and Enhances Radiosensitivity in Non-small Cell Lung Cancer

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2018 May 26
PMID 29793508
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiotherapy is one of the most common and effective treatment methods for cancer, and improving the radiosensitivity of tumor tissues during the treatment process is vital. We report the mechanisms of glycogen synthase kinase 3 (GSK-3) β-regulated autophagy and the effects of autophagy on radiosensitivity in non-small cell lung cancer (NSCLC).

Method: Immunohistochemical staining was performed to determine GSK-3β tissue expression in 89 NSCLC patients with follow-up data and the expression status of GSK-3β and autophagy in NSCLC tissues after X-ray radiotherapy. Western blots were used to quantitate changes in autophagy-related protein expression after A549 cells were treated with GSK-3β inhibitors and after H460 cells were transfected with GSK-3β mutants with different activities and X-ray irradiated. Clonogenic assays were used to measure the effect of autophagy on cellular proliferation.

Results: GSK-3β expression positively correlated with NSCLC differentiation (P < 0.05), and GSK-3β negativity was associated with a better prognosis in 89 NSCLC patients. After X-ray irradiation, the expression levels of GSK-3β and p62 were decreased in NSCLC tissues, and the expression levels of the autophagy-related protein LC3 were increased. A549 and H460 cells were selected as representative GSK-3β-high and GSK-3β-low expression cell lines. After transfecting H460 cells with different GSK-3β mutants [wild type GSK-3β (GSK-3β-WT), constitutively active GSK-3β (GSK-3β-S9A), and catalytically inactive GSK-3β (GSK-3β-K85R)] and subjecting these cells to X-ray irradiation, AMPK and LC3 expression levels decreased, and p62 expression levels increased. These effects were particularly significant for the GSK-3β-S9A mutant. In A549 cells, after GSK-3β inhibition and X-ray irradiation, AMPK and LC3 protein expression levels increased. Moreover, when autophagy was inhibited, cell proliferation decreased.

Conclusion: Our studies revealed that GSK-3β expression is associated with NSCLC differentiation, and patients with GSK-3β-negative tumors had a better prognosis. X-ray irradiation inhibited GSK-3β expression and promoted autophagy. Therefore, GSK-3β inhibits autophagy and enhances the radiosensitivity of NSCLC cells.

Citing Articles

Distinct UPR and Autophagic Functions Define Cell-Specific Responses to Proteotoxic Stress in Microglial and Neuronal Cell Lines.

Dominguez-Martin H, Gavilan E, Parrado C, Burguillos M, Daza P, Ruano D Cells. 2025; 13(24.

PMID: 39768160 PMC: 11674117. DOI: 10.3390/cells13242069.


Mechanism of the combined action of green tea polyphenols and concurrent radiochemotherapy in regulating GSK-3β to treat non-small cell lung cancer through the Wnt∕β-catenin pathway.

Xie K, Wang Y, Chen Z Rom J Morphol Embryol. 2024; 65(3):499-505.

PMID: 39529343 PMC: 11657352. DOI: 10.47162/RJME.65.3.12.


Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts.

Liu H, Wang Q, Lan W, Liu D, Huang J, Yao J Invest New Drugs. 2024; 42(4):405-417.

PMID: 38880855 DOI: 10.1007/s10637-024-01451-1.


BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.

Jin K, Li Y, Wei R, Liu Y, Wang S, Tian H Cell Death Discov. 2024; 10(1):105.

PMID: 38424042 PMC: 10904796. DOI: 10.1038/s41420-024-01879-7.


Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.

Tang C, Liu J, Yang C, Ma J, Chen X, Liu D Biomolecules. 2022; 12(11).

PMID: 36358986 PMC: 9688036. DOI: 10.3390/biom12111636.


References
1.
Chang Z, Shi G, Jin J, Guo H, Guo X, Luo F . Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Int J Mol Med. 2013; 31(6):1449-56. DOI: 10.3892/ijmm.2013.1351. View

2.
Juzenas P, Chen W, Sun Y, Coelho M, Generalov R, Generalova N . Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev. 2008; 60(15):1600-14. PMC: 2695009. DOI: 10.1016/j.addr.2008.08.004. View

3.
Han Y, Wang Y, Xu H, Yang L, Wei Q, Liu Y . X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Int J Radiat Oncol Biol Phys. 2009; 75(2):518-26. DOI: 10.1016/j.ijrobp.2009.05.040. View

4.
Bristol M, Emery S, Maycotte P, Thorburn A, Chakradeo S, Gewirtz D . Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?. J Pharmacol Exp Ther. 2013; 344(3):544-52. PMC: 3583507. DOI: 10.1124/jpet.112.199802. View

5.
Parr C, Carzaniga R, Gentleman S, Van Leuven F, Walter J, Sastre M . Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol. 2012; 32(21):4410-8. PMC: 3486153. DOI: 10.1128/MCB.00930-12. View